ArticleNutrients2009
Hypocholesterolemic effects of nutraceuticals produced from the red microalga Porphyridium sp in rats.
Article in Nutrients, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 106 citations in OpenAlex.
- Antioxidant dipeptide Threonyltyrosine from Porphyridium cruentum: in silico prediction and in vitro protection against paraquat-induced HaCaT cell damage.BMC chemistry · 2026Article
- Effects of Microalgae on Metabolic Syndrome.Antioxidants (Basel, Switzerland) · 2023Review
- Shedding Light on the Hidden Benefit ofAntioxidants (Basel, Switzerland) · 2023Article
- Inside outACS sustainable chemistry & engineering · 2023Article
- Bioactive Compounds from Red Microalgae with Therapeutic and Nutritional Value.Microorganisms · 2022Review
- Regulation of Cholesterol Metabolism by Phytochemicals Derived from Algae and Edible Mushrooms in Non-Alcoholic Fatty Liver Disease.International journal of molecular sciences · 2022Review
- Microalgae-derived polysaccharides: Potential building blocks for biomedical applications.World journal of microbiology & biotechnology · 2022Review
- Microalgae: Bioactive Composition, Health Benefits, Safety and Prospects as Potential High-Value Ingredients for the Functional Food Industry.Foods (Basel, Switzerland) · 2022Review
- Exopolysaccharides from Microalgae and Cyanobacteria: Diversity of Strains, Production Strategies, and Applications.Marine drugs · 2022Review
- Sustainable microalgal biomass production in food industry wastewater for low-cost biorefinery products: a review.Phytochemistry reviews : proceedings of the Phytochemical Society of Europe · 2022Review
- Antioxidant and Signal-Modulating Effects of Brown Seaweed-Derived Compounds against Oxidative Stress-Associated Pathology.Oxidative medicine and cellular longevity · 2021Review
- Article
- The Potential of Cryptophyte Algae in Biomedical and Pharmaceutical Applications.Frontiers in pharmacology · 2020Review
- Microalgal Derivatives as Potential Nutraceutical and Food Supplements for Human Health: A Focus on Cancer Prevention and Interception.Nutrients · 2019Review
- Preventive Effects of the Marine MicroalgaNutrients · 2019Article
- Development of a Green Downstream Process for the Valorization ofMolecules (Basel, Switzerland) · 2019Article
- The Use of Microalgae for Coupling Wastewater Treatment With COFrontiers in bioengineering and biotechnology · 2019Review
- Potential Anti-proliferative and Immunomodulatory Effects of Marine Microalgal Exopolysaccharide on Various Human Cancer Cells and Lymphocytes In Vitro.Marine biotechnology (New York, N.Y.) · 2017Article
- Therapeutic Potentials of Microalgae in the Treatment of Alzheimer's Disease.Molecules (Basel, Switzerland) · 2017Review
- Extracellular Metabolites from Industrial Microalgae and Their Biotechnological Potential.Marine drugs · 2016Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Red microalgae contain functional sulfated polysaccharides (containing dietary fibers), polyunsaturated fatty acids, zeaxanthin, vitamins, minerals, and proteins. Studies in rat models support the therapeutic properties of algal biomass and isolated polysaccharides. Algal products incorporated into rat diets were found to significantly improve total serum cholesterol, serum triglycerides, hepatic cholesterol levels, HDL/LDL ratios and increased fecal excretion of neutral sterols and bile acids. Morphological and metabolic changes were induced by consumption of algal products. These results suggest that red microalgae can be used as potent hypocholesterolemic agents, and they support the potential use of red microalgae as novel nutraceuticals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.